Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma-Reference-Cited by-同舟云学术

Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma

Published:2013-04-29 Issue:3 Volume:44 Page:296-301
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Miyahara Koji¹,Nouso Kazuhiro¹²,Morimoto Yuki¹,Takeuchi Yasuto¹,Hagihara Hiroaki¹,Kuwaki Kenji¹,Onishi Hideki¹²,Ikeda Fusao¹²,Miyake Yasuhiro¹,Nakamura Shinichiro¹,Shiraha Hidenori¹,Takaki Akinobu¹,Iwadou Shouta³,Kobayashi Yoshiyuki³,Takaguchi Koichi⁴,Takuma Yoshitaka⁵,Takabatake Hiroyuki⁵,Sakaguchi Kohsaku⁶,Yamamoto Kazuhide¹,

Affiliation:

1. Department of Gastroenterology and Hepatology; Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences; Okayama Japan

2. Department of Molecular Hepatology; Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences; Okayama Japan

3. Department of Internal Medicine; Hiroshima City Hospital; Hiroshima Japan

4. Department of Hepatology; Kagawa Prefectural Central Hospital; Kagawa Japan

5. Department of Gastroenterology; Kurashiki Central Hospital; Okayama Japan

6. Department of Internal Medicine; Fukuyama City Hospital; Hiroshima Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12123/fullpdf

Reference16 articles.